By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Adaptimmune Ltd. 

57c Milton Park

Abingdon  Oxfordshire  OX14 4RX  United Kingdom
Phone: +44-(0)-1235-438-642 Fax: +44-(0)-1235-438-607


Company News
Adaptimmune Ltd. Announces Interim Results From Pilot Trial Of Its Engineered NY-ESO T Cells Targeting Synovial Sarcoma 10/17/2014 9:37:09 AM
UK Biotech Firm Adaptimmune Ltd. Attracts $104 Million Investment 9/25/2014 6:41:35 AM
Adaptimmune Ltd. Gets Ready To Double Headcount By The End Of 2014 6/4/2014 7:32:20 AM
Adaptimmune Ltd., GlaxoSmithKline (GSK) Strike $350 Million Cancer Immunotherapy Pact 6/2/2014 6:38:21 AM
Adaptimmune Ltd. Integrates BioLife Solutions, Inc. (BLFS.OB) CryoStor® Cell Freeze Media In Cancer Immunotherapy Clinical Trial 4/2/2014 10:55:17 AM
Adaptimmune Ltd. Announces Full-Time Appointment Of James Noble As Chief Executive Officer 3/26/2014 10:59:04 AM
Adaptimmune Ltd. Announces Award Of £2.1 Million From The Biomedical Catalyst Fund 3/25/2014 9:38:06 AM
Adaptimmune Ltd. Announces Interim Results From A Phase I/II Trial Of Engineered T Cells Targeting Cancer Testis Antigens In Multiple Myeloma 12/10/2013 9:49:56 AM
Adaptimmune Ltd. Appoints Dr. Jonathan Knowles As Chairman Of The Board 11/20/2013 3:19:59 PM
Adaptimmune Ltd. Announces Opening of Phase I/IIa Clinical Trial in Ovarian Cancer 7/25/2013 9:33:19 AM